Milestone Pharmaceuticals (MIST) Operating Expenses: 2020-2021

Historic Operating Expenses for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2021 value amounting to $51.1 million.

  • Milestone Pharmaceuticals' Operating Expenses rose 9.19% to $13.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $52.5 million, marking a year-over-year change of. This contributed to the annual value of $51.1 million for FY2021, which is 14.06% up from last year.
  • Milestone Pharmaceuticals' Operating Expenses amounted to $51.1 million in FY2021, which was up 14.06% from $44.8 million recorded in FY2020.
  • Milestone Pharmaceuticals' Operating Expenses' 5-year high stood at $51.1 million during FY2021, with a 5-year trough of $44.8 million in FY2020.
  • For the 2-year period, Milestone Pharmaceuticals' Operating Expenses averaged around $47.9 million, with its median value being $47.9 million (2020).
  • Data for Milestone Pharmaceuticals' Operating Expenses shows a peak YoY increased of 14.06% (in 2021) over the last 5 years.
  • Over the past 2 years, Milestone Pharmaceuticals' Operating Expenses (Yearly) stood at $44.8 million in 2020, then increased by 14.06% to $51.1 million in 2021.